title: [Risk of atherosclerosis development in patients with systemic lupus erythematosus].
authors.affiliation: Katedra i Klinika Chorób Wewnetrznych i Reumatologii Sl. AM w Katowicach. pkotyla@slam.katowice.pl
authors.forename: Przemysław J
authors.initials: PJ
authors.lastname: Kotyla
authors.forename: Bogna
authors.initials: B
authors.lastname: Sliwińska-Kotyla
authors.forename: Maciej
authors.initials: M
authors.lastname: Lewicki
authors.forename: Eugeniusz J
authors.initials: EJ
authors.lastname: Kucharz
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000139:chemically induced / Q000453:epidemiology*; D001323:Autoantibodies / Q000009:adverse effects / Q000097:blood; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology; D015984:Causality; D015897:Comorbidity; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D018450:Disease Progression; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D009203:Myocardial Infarction / Q000453:epidemiology; D012307:Risk Factors
chemical_list: D000305:Adrenal Cortex Hormones; D001323:Autoantibodies; D016572:Cyclosporine; D001379:Azathioprine